Keane Inc., a formerly public (USD 1 billion-plus) software firm has won a $1.4 million, three-year deal with Parkway Hospital in Queens, New York, for a patient-management software product. That deal came the day after Keane announced a similar USD 1.2 million contract with Century City Doctors Hospital in Los Angeles.
Mumbai-Based business process outsourcing company Accentia Technologies has reportedly acquired three US-based healthcare BPO companies for about INR 800 million, sources close to the deal said.
Omega Healthcare, provider of healthcare BPO and KPO services, has announced growth plans for its Indian operations over the next 18-24 months. The Company plans to invest over $14 million to expand its Bangalore and Chennai facilities and will more than double its employee base to 3,000.
The multi-million dollar Hinduja group has finally revealed its plans of investing in India’s sunrise sectors like healthcare and insurance.
The software giant is encouraging companies to develop RFID applications for the free online medical database service it recently launched.
Fortis, one of India
Perot Systems, the second largest solution providers for the healthcare vertical in the US, having a $1.25 billion business in the healthcare industry, recently set up shop in Tamil Nadu.
In India, the solution provider now has set-ups in Chennai and Coimbatore (in Tamil Nadu) apart from ones in Bangalore and Noida.
Recently, Arizona Health-e Connection has received the national innovation award for its best practices in promoting healthcare IT adoption for its state.
GE Healthcare
A unit of General Electric Co., GE Healthcare Technologies Ltd, has received approval from India
Cryobanks International India(CII), a JV between Cryobanks International Inc of US, and RJ Corp of India, is planning to invest Rs 500 crore in the health care industry in the country over the next five years.
Sobha Renaissance Information Technology (SRIT) have announced its Joint Venture (JV) with Capital Technic Group (CTG), an Australian Management Consulting & Services firm. The joint-venture capitalized at Australian $2.5m aims to produce $7.5m in annual revenues by the second year and ramping up to $65m by the fifth.
Pharma major Wockhardt is planning to triple or quadruple the company
